Given that PolI silencing induces NF-κB (RelA) displacement to the nucleolus (Stark and Dunlop, 2005), the PolI inhibitor BMH-21 may be used to sensitize cancer cells to apoptosis (Peltonen et al., 2014). Here, NFKB1 is linked to cancer.